Search Results - "Zeind, J"

Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover by ROSEN, H. N, DRESNER-POLLAK, R, MOSES, A. C, ROSENBLATT, M, ZEIND, A. J, CLEMENS, J. D, GREENSPAN, S. L

“…Urinary excretion of cross-linked N-telopeptide of type I collagen (NTX) has been reported to be a specific indicator of bone resorption. We studied the…”
Get full text

Biliary excretion of plasma non-transferrin-bound iron in rats: pathogenetic importance in iron-overload disorders by Brissot, P, Zanninelli, G, Guyader, D, Zeind, J, Gollan, J

“…Plasma non-transferrin-bound iron (NTB-iron) is a potentially toxic form of iron, which is efficiently taken up by the normal, as well as the chronically…”
Get full text

ADENOSINE TRIPHOSPHATE-SENSITIVE K+ CHANNELS MEDIATE POSTCARDIOPLEGIA CORONARY HYPEREMIA by Wang, Steven Y, Friedman, Menachem, Johnson, Robert G, Zeind, Adib J, Sellke, Frank W

“…The purpose of the present study was to examine the role of adenosine triphosphate-sensitive potassium channels in mediating the coronary hyperemic response…”
Get full text

Intracellular calcium and ventricular function : effects of nisoldipine on global ischemia in the isovolumic, coronary-perfused heart by AMENDE, I, BENTIVEGNA, L.A, ZEIND, A. J, WENZLAFF, P, GROSSMAN, W, MORGAN, J. P

“…Ischemia-induced ventricular dysfunction has been shown to be associated with increased diastolic and systolic intracellular concentrations of free, ionized…”
Get full text

Finasteride therapy does not alter bone turnover in men with benign prostatic hyperplasia : A clinical research center study by TOLLIN, S. R, ROSEN, H. N, ZUROWSKI, K, SALTZMAN, B, ZEIND, A. J, BERG, S, GREENSPAN, S. L

“…Benign prostatic hyperplasia is often treated with finasteride, which inhibits the conversion of testosterone to dihydrotestosterone (DHT). Aside from the…”
Get full text

Further study and characterization of the yellow pigments in follicular fluid that are related to oocyte quality by Bayer, S R, Zeind, A J, Turksoy, R N, Emmi, A M, Reindollar, R H

“…To characterize the 455-nm (yellow) absorbing pigments in human follicular fluid (FF). Serum and FF samples obtained from patients undergoing in vitro…”
Get more information

Chicken soup revisited : calcium content of soup increases with duration of cooking by ROSEN, H. N, SALEMME, H, ZEIND, A. J, MOSES, A. C, SHAPIRO, A, GREENSPAN, S. L

“…Because low dietary calcium intake may accelerate bone loss, patients often are advised to increase their dietary intake of calcium. However, some patients may…”
Get full text

Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload by Chen, K, Suh, J, Carr, A C, Morrow, J D, Zeind, J, Frei, B

“…Ascorbate is a strong antioxidant; however, it can also act as a prooxidant in vitro by reducing transition metals. To investigate the in vivo relevance of…”
Get more information

Inhibition of copper-induced LDL oxidation by vitamin C is associated with decreased copper-binding to LDL and 2-oxo-histidine formation by Retsky, Karen L., Chen, Kent, Zeind, John, Frei, Balz

“…Oxidatively modified low-density lipoprotein (LDL) has numerous atherogenic properties, and antioxidants that can prevent LDL oxidation may act as…”
Get full text

Mechanism of suppression of cardiac L-type Ca2+ currents by the phospholipase A2 inhibitor mepacrine by XIAO, Y.-F, ZEIND, A. J, KAUSHIK, V, PERREAULT-MICALE, C. L, MORGAN, J. P

Get full text

The tensile behavior of demineralized bovine cortical bone by Bowman, Steven M., Zeind, John, Gibson, Lorna J., Hayes, Wilson C., McMahon, Thomas A.

“…Bone is frequently modeled as a two-phase composite of hydroxyapatite mineral crystals dispersed throughout an organic collagen matrix. However, because of the…”
Get full text

Bone density is normal in male rats treated with finasteride by Rosen, H N, Tollin, S, Balena, R, Middlebrooks, V L, Moses, A C, Yamamoto, M, Zeind, A J, Greenspan, S L

“…Bone is an androgen-dependent tissue. It is not known whether normal bony growth and mineralization in males is dependent on testosterone alone, or whether its…”
Get more information

Activation of Cl secretion during chemical hypoxia by endogenous release of adenosine in intestinal epithelial monolayers by Matthews, J B, Tally, K J, Smith, J A, Zeind, A J, Hrnjez, B J

“…Intestinal ischemia is characterized by rapid early inhibition of absorptive function and the appearance of net secretion, although why active secretion…”
Get full text

Parenteral pamidronate prevents thyroid hormone‐induced bone loss in rats by Rosen, Harold N., Sullivan, E. Kelly, Middlebrooks, V. Leah, Zeind, Adib John, Gundberg, Caren, Dresner‐Pollak, Rivka, Maitland, Lauri A., Hock, Janet M., Moses, Alan C., Greenspan, Susan L.

“…Pamidronate (APD) is a bisphosphonate that prevents bone loss from a variety of causes. We studied the role of APD in preventing thyroid hormone‐induced bone…”
Get full text

Mechanism of suppression of cardiac L-type Ca(2+) currents by the phospholipase A(2) inhibitor mepacrine by Xiao, Y F, Zeind, A J, Kaushik, V, Perreault-Micale, C L, Morgan, J P

“…Phospholipase A(2) plays a crucial role in the release of arachidonic acid (AA) from membrane phospholipids and in myocardial injury during ischemia and…”
Get full text

Mechanism of suppression of cardiac L-type Ca 2+ currents by the phospholipase A 2 inhibitor mepacrine by Xiao, Yong-Fu, Zeind, Adib J., Kaushik, Vinit, Perreault-Micale, Cynthia L., Morgan, James P.

“…Phospholipase A 2 plays a crucial role in the release of arachidonic acid (AA) from membrane phospholipids and in myocardial injury during ischemia and…”
Get full text

Adenosine triphosphate-sensitive K + channels mediate postcard ioplegia coronary hyperemia by Wang, Steven Y., Friedman, Menachem, Johnson, Robert G., Zeind, Adib J., Sellke, Frank W.

“…The purpose of the present study was to examine the role of adenosine triphosphate-sensitive potassium channels in mediating the coronary hyperemic response…”
Get full text

Finasteride therapy does not alter bone turnover in men with benign prostatic hyperplasia--a Clinical Research Center study by Tollin, S R, Rosen, H N, Zurowski, K, Saltzman, B, Zeind, A J, Berg, S, Greenspan, S L

Get full text